Skip to main content
. 2021 Apr 30;11:672047. doi: 10.3389/fonc.2021.672047

Figure 2.

Figure 2

T1-weighted image, T2-weighted image and parametric maps (D*, f, D, ADC and R2*) of a representative mouse treated with bevacizumab combined with TH-302 before and at different times after treatment.